TERF1 and cancer: Although the relevant research is rapidly evolving, highlighting the necessity for further biological studies, the current literature proposes that in cancer cells, it inhibits telomerase activity [86,87,88], consistent with findings for other flavonoids [85,88], while concurrently selectively modulating the expression of POT1, TRF1, and TRF2 proteins [89].